FDA approves daratumumab and hyaluronidase-fihj for high-risk smoldering multiple myeloma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daratumumab-and-hyaluronidase-fihj-high-risk-smoldering-multiple-myeloma